Alternatives to Tru2u

The lowest medication price on this roster, and a headline that still leaves out a required charge. Compounded semaglutide is $59 a month and tirzepatide $69, flat at every dose and cancellable at any time — both requiring a $199 annual membership the pricing line never mentions. Counted properly the first year is $907 for semaglutide, about $76 a month, and $1,027 for tirzepatide, about $86, which remains among the cheapest anywhere even after the fee. It is operated by Health For Everyone Inc., trading as CollectiveOS, and positioned on being brought to you by the founder of Thrive Market and on GLP-1s without the 500% markup. There is a 21-day free trial before the membership charge, after which the fee is non-refundable with no partial periods returned. The compounding pharmacies are never named, no state list is published, and no time to first dose is given.

Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.

A sublingual (under-the-tongue), not injectable, GLP-1 program — $189/mo semaglutide and $319/mo tirzepatide on a 6-month prepay plan, $209/mo and $359/mo on a shorter 2-month plan — serving 34 states plus DC.

Cost this at the dose you will end up on, not the one you start at. Tirzepatide runs $280 per four weeks at 2.5 mg and $525 at 15 mg — thirteen cycles a year, so $3,640 against $6,825. Semaglutide is stranger: two of its five levels cover five weeks rather than four, which makes level three cheaper per week than level two despite the higher dose, and contradicts the sentence directly above the table.

The sum is transparent and it is the seller's own: $99 a month for the service, plus the manufacturer's charge — $299 for the Zepbound starter pen, $149 for the Wegovy pill — giving $398 and $248. The first month is $25 instead of $99. Both of those manufacturer figures are LillyDirect's and NovoCare's own, so the arithmetic can be checked from outside, and it holds. What is not published is the ladder as your dose climbs.

A one-product shop — compounded tirzepatide microdosing only, $89 the first month then $199/mo all-in, no live video visit described anywhere in the flow, and unusually candid on-site that the trial evidence for microdosing specifically is thin — but there's no semaglutide option at all, and no individual physician, pharmacy, or state list named anywhere on the site checked.

Names four specific 503A compounding pharmacy partners directly — from $150/mo semaglutide, $241/mo tirzepatide on a 6-month plan, available as injection, drops, or pills — though state coverage isn't published.

The billing cycle is stated in the same sentence as the price, so the year is countable without guesswork: thirteen charges of $149 is $1,937 for semaglutide and $2,587 for tirzepatide. Both are founding rates the site says will rise to $179 and $249 — $2,327 and $3,237 a year. What you cannot read is any of its legal documents, because they are the homepage with a different title on the tab.

A no-membership-fee, quarterly-billed program — $167/mo semaglutide, $267/mo tirzepatide — bundling a GLP-1 fitness app, meal plans, and 1-on-1 nutrition coaching that most compounded-only competitors don't offer. It also publishes its own named comparison against Ro, Mochi Health, TrimRx, and Hims, an unusually direct move for this category.